Assembly Biosciences Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -19.2% | +47.5% | -19.8% | +7.5% | +28.0% | +2.2% | +12.1% | +293.6% | -80.7% | +62.8% | – | |
| – | -99.2% | -61.9% | +0.0% | +42,134.4% | +5.7% | +4.0% | +8.6% | +2.9% | -99.8% | -18.8% | -23.1% | – | |
| – | – | -18.7% | +47.8% | -178.5% | – | – | – | – | – | -80.7% | +63.1% | – | |
| – | +1.7% | +7.9% | +36.9% | -16.9% | +5.7% | +4.0% | +8.6% | +2.9% | +4.0% | -13.6% | +0.1% | – | |
| – | +106.2% | -46.8% | -3.4% | -4.3% | +7.5% | -2.2% | +1.9% | +10.7% | +6.6% | -13.6% | +2.5% | – | |
| – | +364.7% | -16.0% | +25.6% | -79.3% | +7.5% | -2.2% | +1.9% | +10.7% | +345.8% | -13.6% | +0.6% | – | |
| – | – | – | – | – | – | – | – | – | – | -157.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | -141.1% | – | – | |
| – | – | -134.2% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -141.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | -140.9% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.